Literature DB >> 3829884

Steatosis and cirrhosis in an obese diabetic. Resolution of fatty liver by fasting.

E B Keeffe, P W Adesman, P Stenzel, R M Palmer.   

Abstract

A 54-year-old woman with obesity, type II diabetes mellitus, hyperlipidemia, and massive hepatomegaly was found to have severe steatosis and cirrhosis on liver biopsy. Complete evaluation led to the diagnosis of fatty cirrhosis associated with obesity and diabetic mellitus. She underwent four months of fasting with a protein-carbohydrate and vitamin-mineral liquid supplement to control her weight and metabolic abnormalities and to evaluate the effect of this diet on her liver disease. She lost 40 pounds to ideal body weight, normalized her serum glucose and lipids, and decreased total liver height by one third. Liver biopsy at the completion of her diet showed inactive cirrhosis and complete resolution of steatosis. Supplemented fasting with only modest weight loss can safely resolve fatty liver in obese diabetics with nonalcoholic steatosis and cirrhosis. Aggressive dietary approaches to achieve long-term weight loss deserve study in this subgroup of diabetics with unexplained chronic liver disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3829884     DOI: 10.1007/bf01296300

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  12 in total

1.  METABOLIC CHANGES ASSOCIATED WITH OBESITY BEFORE AND AFTER WEIGHT REDUCTION.

Authors:  D BERKOWITZ
Journal:  JAMA       Date:  1964-02-08       Impact factor: 56.272

2.  Fatty metamorphosis of the liver in morbid obesity.

Authors:  W H Kern; A H Heger; J H Payne; L T DeWind
Journal:  Arch Pathol       Date:  1973-11

3.  Relationship between 505 paired liver tests and biopsies in 242 obese patients.

Authors:  J T Galambos; C E Wills
Journal:  Gastroenterology       Date:  1978-06       Impact factor: 22.682

4.  Relationship between hepatic morphology and clinical and biochemical findings in morbidly obese patients.

Authors:  J L Manes; H B Taylor; G B Starkloff
Journal:  J Clin Pathol       Date:  1973-10       Impact factor: 3.411

5.  Hepatic lesions of central pericellular fibrosis in morbid obesity, and after jejunoileal bypass.

Authors:  A T Marubbio; H Buchwald; M Z Schwartz; R Varco
Journal:  Am J Clin Pathol       Date:  1976-10       Impact factor: 2.493

6.  Nonalcoholic steatohepatitis and cirrhosis with Mallory's hyalin with ultrastructural study of one case.

Authors:  S Itoh; S Matsuo; A Ichinoe; Y Yamaba; M Miyazawa
Journal:  Dig Dis Sci       Date:  1982-04       Impact factor: 3.199

7.  Pericentral hepatic fibrosis and intracellular hyalin in diabetes mellitus.

Authors:  K R Falchuk; S C Fiske; R C Haggitt; M Federman; C Trey
Journal:  Gastroenterology       Date:  1980-03       Impact factor: 22.682

8.  Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.

Authors:  J Ludwig; T R Viggiano; D B McGill; B J Oh
Journal:  Mayo Clin Proc       Date:  1980-07       Impact factor: 7.616

9.  Fatty liver hepatitis and cirrhosis in obese patients.

Authors:  M Adler; F Schaffner
Journal:  Am J Med       Date:  1979-11       Impact factor: 4.965

10.  Hepatic morphology in obesity.

Authors:  S M Nasrallah; C E Wills; J T Galambos
Journal:  Dig Dis Sci       Date:  1981-04       Impact factor: 3.199

View more
  7 in total

1.  Therapeutic Options in Nonalcoholic Fatty Liver Disease.

Authors:  Jeffrey L. Tokar; Carl L. Berg
Journal:  Curr Treat Options Gastroenterol       Date:  2002-12

Review 2.  Nonalcoholic fatty liver disease.

Authors:  Z M Younossi
Journal:  Curr Gastroenterol Rep       Date:  1999 Feb-Mar

3.  Dietary composition and nonalcoholic fatty liver disease.

Authors:  Steven Solga; Amir R Alkhuraishe; Jeanne M Clark; Mike Torbenson; Ashli Greenwald; Anna Mae Diehl; Thomas Magnuson
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

4.  Non-alcoholic fatty liver disease and the metabolic syndrome: effects of weight loss and a review of popular diets. Are low carbohydrate diets the answer?

Authors:  Harjot K Gill; George Y Wu
Journal:  World J Gastroenterol       Date:  2006-01-21       Impact factor: 5.742

5.  Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients.

Authors:  H C Pinto; A Baptista; M E Camilo; A Valente; A Saragoça; M C de Moura
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

6.  Long working hours and overweight and obesity in working adults.

Authors:  Byung-Mi Kim; Bo-Eun Lee; Hye-Sook Park; Young-Ju Kim; Young-Ju Suh; Jeong-Youn Kim; Ji-Young Shin; Eun-Hee Ha
Journal:  Ann Occup Environ Med       Date:  2016-08-22

7.  Efficacy and Safety of Weight Reduction of the Donor in Hepatic Steatosis for Living Donor Liver Transplantation.

Authors:  Jae Hun Chung; Je Ho Ryu; Kwang Ho Yang; Byung Hyun Choi; Youngmok Park; Tae Beom Lee; Jae Ryong Shim; Hyo Jung Ko; Sung Hwan Cho
Journal:  Ann Transplant       Date:  2020-07-21       Impact factor: 1.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.